Drug Information

Drug General Information
Drug ID
D0K6BI
Former ID
DIB019412
Drug Name
compound 2c
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531713]
Formula
C11H9Br4N3O2
InChI
InChI=1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)
InChIKey
PHAOTASRLQMKBE-UHFFFAOYSA-N
PubChem Compound ID
46943415
PubChem Substance ID
99455504, 104249971, 120941427, 136367060, 136963870, 152344540, 188919900, 227938892, 241376575, 248709751, 249565820, 252157444
Target and Pathway
Target(s) casein kinase 2, alpha prime polypeptide subunit Target Info Inhibitor [531713]
Casein kinase II, alpha chain Target Info Inhibitor [531713]
KEGG Pathway Ribosome biogenesis in eukaryotes
NF-kappa B signaling pathway
Wnt signaling pathway
Adherens junction
Tight junction
Measles
Herpes simplex infection
Epstein-Barr virus infection
NetPath Pathway FSH Signaling Pathway
Pathway Interaction Database BCR signaling pathway
Atypical NF-kappaB pathway
DNA-PK pathway in nonhomologous end joining
Presenilin action in Notch and Wnt signaling
Role of Calcineurin-dependent NFAT signaling in lymphocytes
E-cadherin signaling in the nascent adherens junction
Lissencephaly gene (LIS1) in neuronal migration and development
PDGFR-alpha signaling pathway
Signaling mediated by p38-alpha and p38-beta
Alpha-synuclein signaling
Reactome Condensation of Prometaphase Chromosomes
WikiPathways Mitotic Prometaphase
BDNF signaling pathway
TNF alpha Signaling Pathway
L1CAM interactions
References
Ref 531713CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50.
Ref 531713CK2alpha and CK2alpha' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives. Eur J Med Chem. 2012 Jan;47(1):345-50.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.